<DOC>
	<DOCNO>NCT00676689</DOCNO>
	<brief_summary>To assess safety effectiveness pulmonic THV implantation subject dysfunctional RVOT conduit require treatment moderate severe pulmonary regurgitation ( ≥3+ pulmonary regurgitation ) and/or RVOT conduit obstruction ( mean gradient &gt; =35mmHg ) TTE .</brief_summary>
	<brief_title>COMPASSION - COngenital Multicenter Trial Pulmonic VAlve Regurgitation Studying SAPIEN InterventIONal THV</brief_title>
	<detailed_description>The study design multi-center , prospective , non-randomized study 70 implanted subject ( US ) site represent 30 % implanted subject . The subject include subject previously undergone placement conduit right ventricle pulmonary artery present dysfunctional RVOT conduit require treatment moderate severe pulmonary regurgitation and/or RVOT conduit obstruction .</detailed_description>
	<mesh_term>Pulmonary Valve Stenosis</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Inclusion Criteria 1 . Weight must equal exceed 35 kilogram . 2 . In situ conduit size ≥ 16 mm ≤ 24 mm diameter . 3 . Subject present moderate severe pulmonary regurgitation define ≥3+ pulmonary regurgitation TTE RVOT conduit obstruction mean gradient &gt; = 35 mmHg TTE . 4 . Subject symptomatic evidence cardiopulmonary exercise testing . 5 . The subject subject 's legal representative inform nature study , agree provision provide write informed consent approve Institutional Review Board ( IRB ) respective clinical site . 6 . The subject treating physician agree subject return require postprocedure follow visit subject comply protocolrequired followup visit . 7 . Catheterization determine feasible treat physician . Exclusion Criteria 1 . Active infection require current antibiotic therapy ( temporary illness , subject may candidate 4 week discontinuation antibiotic ) 2 . Previously enrol study . 3 . Subject preexist prosthetic heart valves position* . 4 . Severe chest wall deformity . 5 . Leukopenia ( WBC &lt; 3000 mm3 ) . 6 . Acute chronic anemia ( Hb &lt; 9 g/dL ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pulmonic</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Pulmonary Valve Conduit</keyword>
	<keyword>Stenosis</keyword>
	<keyword>Congenital Heart Defect</keyword>
</DOC>